TY - JOUR
T1 - A novel super-resolution microscopy platform for cutaneous alpha-synuclein detection in Parkinson’s disease
AU - Sade, Ofir
AU - Fischel, Daphna
AU - Barak-Broner, Noa
AU - Halevi, Shir
AU - Gottfried, Irit
AU - Bar-On, Dana
AU - Sachs, Stefan
AU - Mirelman, Anat
AU - Thaler, Avner
AU - Gour, Aviv
AU - Kestenbaum, Meir
AU - Gana Weisz, Mali
AU - Anis, Saar
AU - Soto, Claudio
AU - Roitman, Melanie Shanie
AU - Shahar, Shimon
AU - Doppler, Kathrin
AU - Sauer, Markus
AU - Giladi, Nir
AU - Lev, Nirit
AU - Alcalay, Roy N.
AU - Hassin-Baer, Sharon
AU - Ashery, Uri
N1 - Publisher Copyright: Copyright © 2024 Sade, Fischel, Barak-Broner, Halevi, Gottfried, Bar-On, Sachs, Mirelman, Thaler, Gour, Kestenbaum, Gana Weisz, Anis, Soto, Roitman, Shahar, Doppler, Sauer, Giladi, Lev, Alcalay, Hassin-Baer, and Ashery.
PY - 2024/1/1
Y1 - 2024/1/1
N2 - Alpha-synuclein (aSyn) aggregates in the central nervous system are the main pathological hallmark of Parkinson’s disease (PD). ASyn aggregates have also been detected in many peripheral tissues, including the skin, thus providing a novel and accessible target tissue for the detection of PD pathology. Still, a well-established validated quantitative biomarker for early diagnosis of PD that also allows for tracking of disease progression remains lacking. The main goal of this research was to characterize aSyn aggregates in skin biopsies as a comparative and quantitative measure for PD pathology. Using direct stochastic optical reconstruction microscopy (dSTORM) and computational tools, we imaged total and phosphorylated-aSyn at the single molecule level in sweat glands and nerve bundles of skin biopsies from healthy controls (HCs) and PD patients. We developed a user-friendly analysis platform that offers a comprehensive toolkit for researchers that combines analysis algorithms and applies a series of cluster analysis algorithms (i.e., DBSCAN and FOCAL) onto dSTORM images. Using this platform, we found a significant decrease in the ratio of the numbers of neuronal marker molecules to phosphorylated-aSyn molecules, suggesting the existence of damaged nerve cells in fibers highly enriched with phosphorylated-aSyn molecules. Furthermore, our analysis found a higher number of aSyn aggregates in PD subjects than in HC subjects, with differences in aggregate size, density, and number of molecules per aggregate. On average, aSyn aggregate radii ranged between 40 and 200 nm and presented an average density of 0.001–0.1 molecules/nm2. Our dSTORM analysis thus highlights the potential of our platform for identifying quantitative characteristics of aSyn distribution in skin biopsies not previously described for PD patients while offering valuable insight into PD pathology by elucidating patient aSyn aggregation status.
AB - Alpha-synuclein (aSyn) aggregates in the central nervous system are the main pathological hallmark of Parkinson’s disease (PD). ASyn aggregates have also been detected in many peripheral tissues, including the skin, thus providing a novel and accessible target tissue for the detection of PD pathology. Still, a well-established validated quantitative biomarker for early diagnosis of PD that also allows for tracking of disease progression remains lacking. The main goal of this research was to characterize aSyn aggregates in skin biopsies as a comparative and quantitative measure for PD pathology. Using direct stochastic optical reconstruction microscopy (dSTORM) and computational tools, we imaged total and phosphorylated-aSyn at the single molecule level in sweat glands and nerve bundles of skin biopsies from healthy controls (HCs) and PD patients. We developed a user-friendly analysis platform that offers a comprehensive toolkit for researchers that combines analysis algorithms and applies a series of cluster analysis algorithms (i.e., DBSCAN and FOCAL) onto dSTORM images. Using this platform, we found a significant decrease in the ratio of the numbers of neuronal marker molecules to phosphorylated-aSyn molecules, suggesting the existence of damaged nerve cells in fibers highly enriched with phosphorylated-aSyn molecules. Furthermore, our analysis found a higher number of aSyn aggregates in PD subjects than in HC subjects, with differences in aggregate size, density, and number of molecules per aggregate. On average, aSyn aggregate radii ranged between 40 and 200 nm and presented an average density of 0.001–0.1 molecules/nm2. Our dSTORM analysis thus highlights the potential of our platform for identifying quantitative characteristics of aSyn distribution in skin biopsies not previously described for PD patients while offering valuable insight into PD pathology by elucidating patient aSyn aggregation status.
KW - Parkinson’s disease
KW - alpha-synuclein aggregates
KW - biomarker
KW - density-based spatial clustering of applications with noise (DBSCAN)
KW - direct stochastic optical reconstruction microscopy (dSTORM)
KW - early diagnosis
KW - fast optimized cluster algorithm for localizations (FOCAL)
KW - super-resolution microscopy
UR - http://www.scopus.com/inward/record.url?scp=85204436897&partnerID=8YFLogxK
U2 - https://doi.org/10.3389/fnmol.2024.1431549
DO - https://doi.org/10.3389/fnmol.2024.1431549
M3 - Article
C2 - 39296283
SN - 1662-5099
VL - 17
JO - Frontiers in Molecular Neuroscience
JF - Frontiers in Molecular Neuroscience
M1 - 1431549
ER -